Sickle cell CRISPR ' cure ' is the start of a revolution in medicine

The approval of a first CRISPR treatment, for sickle cell disease and beta thalassemia, is just the start for a technology still in its infancy
Source: New Scientist - Health - Category: Consumer Health News Source Type: research